Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03715452 · ClinicalTrials.gov registry record
DyeVert™ Plus Contrast Reduction System Multicenter Observational Study
A clinical trial of Chronic Kidney Disease, sponsored by Osprey Medical.
- Completed
- Registry status
- 114
- Enrollment target
- 8
- Study locations
NCT03715452: Completed study of Chronic Kidney Disease, sponsored by Osprey Medical.
NCT03715452 is a study of Chronic Kidney Disease that has completed, run by Osprey Medical. The registered enrollment target is 114 participants, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (96% lower). The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03715452, a study of Chronic Kidney Disease, has completed, sponsored by Osprey Medical.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a prospective, single arm, multi-center, observational clinical study of the DyeVert Plus System. The DyeVert Plus System is an FDA-cleared device designed to reduce contrast media volume delivered during angiography and permit real-time contrast media volume monitoring.
Primary Outcome
The percentage of contrast media volume saved (diverted) over the total procedure as reported on the DyeVert Plus display at the end of each case.
Conditions Studied
Interventions
- DEVICE DyeVert Plus Contrast Reduction System
Study Locations (8)
California
- Harbor UCLA Medical Center - Torrance
Georgia
- Atlanta VA Medical Center, Emory University School of Medicine - Atlanta
Illinois
- University of Chicago Medical Center - Chicago
Michigan
- William Beaumont Hospital - Royal Oak
Mississippi
- North Mississippi Medical Center - Tupelo
Missouri
- Washington University School of Medicine - St Louis
North Carolina
- WakeMed Heart and Vascular - Raleigh
Ohio
- Christ Hospital, Heart and Vascular Center, Lindner Research Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2018-03-30 |
What the finished NCT03715452 record still lists
NCT03715452 is an observational study that tracks outcomes without assigning an intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which DyeVert Plus Contrast Reduction System is the first listed.
NCT03715452 lists 8 locations in 8 states (California, Georgia, Illinois).
Frequently Asked Questions
What is clinical trial NCT03715452 about?
NCT03715452 is a clinical study titled "DyeVert™ Plus Contrast Reduction System Multicenter Observational Study". This is a prospective, single arm, multi-center, observational clinical study of the DyeVert Plus System. The DyeVert Plus System is an FDA-cleared device designed to reduce contrast media volume delivered during angiography and permit real-time contrast media volume monitoring.
What is the current status of trial NCT03715452?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2017-07-01. Estimated completion is 2018-03-30.
What conditions does trial NCT03715452 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
What interventions are being tested in trial NCT03715452?
The interventions under investigation include: DyeVert Plus Contrast Reduction System (DEVICE).
Who is sponsoring clinical trial NCT03715452?
This trial is sponsored by Osprey Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03715452 being conducted?
This trial has 8 study locations across California, Georgia, Illinois, Michigan, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03715452's enrollment target sits among peer trials
114 53rd of 101 higher than 49 of 101 other Chronic Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
RECRUITING · Phase 2
-
Patient-driven Management of BP in CKD
RECRUITING · Phase 3
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
RECRUITING · Phase 4
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI